Li Jingyang increased his holding of Huakang Biomed (08622) by approximately 139 million shares, with a price of 0.1175 Hong Kong dollars per share.
On January 10th, Li Jingyang increased his holdings of Huakang Biomedical (08622) by 138.672 million shares, with a price of 0.1175 Hong Kong dollars per share, for a total amount of 16.29396 million Hong Kong dollars.
According to the latest information from the Hong Kong Stock Exchange, on January 10th, Li Jingyang increased his holdings of Huakang Biomedical (08622) by 138.672 million shares, at a price of HK$0.1175 per share, for a total amount of HK$16.29396 million. After the increase, the latest number of shares held is 138.672 million, with a latest shareholding percentage of 27.71%.
Related Articles
.png)
IPO news | Keen Gene submits application to Hong Kong Stock Exchange
JACOBIO-B(01167) subsidiary enters into licensing and collaboration agreement with AstraZeneca to develop and commercialize the pan-KRAS inhibitor JAB-23E73.
China Securities Co., Ltd.: Three clues for A-share investment at the end of the year and the beginning of the year.
IPO news | Keen Gene submits application to Hong Kong Stock Exchange
JACOBIO-B(01167) subsidiary enters into licensing and collaboration agreement with AstraZeneca to develop and commercialize the pan-KRAS inhibitor JAB-23E73.
China Securities Co., Ltd.: Three clues for A-share investment at the end of the year and the beginning of the year.
